mCSM-membrane
mCSM-membrane predicts the effects of single-point mutations on transmembrane proteins by assessing mutation-induced changes in protein stability and pathogenicity.
Key Features:
- Graph-based signature approach: Represents protein geometry and physicochemical properties with graph-based signatures for mutation modelling.
- Supervised learning: Uses supervised learning models to predict changes in stability and to classify mutation pathogenicity.
- Performance metrics: Stability predictor achieves correlations up to 0.72 in cross-validation and 0.67 in blind tests; pathogenicity predictor achieves Matthew's Correlation Coefficient (MCC) up to 0.77 in cross-validation and 0.73 in blind tests.
Scientific Applications:
- Structural and functional impact analysis: Predicts how single-point mutations affect the structure and function of transmembrane proteins.
- Disease variant identification: Identifies potentially disease-associated variants in membrane proteins by assessing pathogenicity.
- Experimental planning: Prioritizes mutations to guide empirical validation and experimental design.
Methodology:
Represents protein geometry and physicochemical properties using graph-based signatures and applies supervised learning models, with performance evaluated by cross-validation and blind tests.
Topics
Details
- Tool Type:
- api
- Added:
- 1/18/2021
- Last Updated:
- 11/24/2024
Operations
Publications
Pires DEV, Rodrigues CHM, Ascher DB. mCSM-membrane: predicting the effects of mutations on transmembrane proteins. Nucleic Acids Research. 2020;48(W1):W147-W153. doi:10.1093/nar/gkaa416. PMID:32469063. PMCID:PMC7319563.
DOI: 10.1093/nar/gkaa416
PMID: 32469063
PMCID: PMC7319563
Funding: - Fundação de Amparo à Pesquisa do Estado de Minas Gerais: MR/M026302/1
- Jack Brockhoff Foundation: JBF 4186
- Wellcome Trust: 200814/Z/16/Z
- National Health and Medical Research Council: GNT1174405